======= KRI1 ======= == Gene Information == * **Official Symbol**: KRI1 * **Official Name**: KRI1 homolog * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=65095|65095]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N9T8|Q8N9T8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KRI1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KRI1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/621355|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Kri1| |Kri1 C| |endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)| |90S preribosome| |endonucleolytic cleavage involved in rRNA processing| |endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)| |maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)| |cleavage involved in rRNA processing| |maturation of 5.8S rRNA| |maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)| |maturation of SSU-rRNA| |ribosomal small subunit biogenesis| |RNA phosphodiester bond hydrolysis, endonucleolytic| |RNA phosphodiester bond hydrolysis| |rRNA processing| |rRNA metabolic process| |nucleic acid phosphodiester bond hydrolysis| |ribosome biogenesis| |ncRNA processing| |ribonucleoprotein complex biogenesis| |ncRNA metabolic process| |nucleolus| |RNA processing| |RNA binding| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-2.51| |[[:results:exp326|CCT251545 20μM R07 exp326]]|-2.3| |[[:results:exp33|Rotenone 2μM R00 exp33]]|-2.08| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.01| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.91| |[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.9| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.89| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|-1.87| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-1.73| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|1.75| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.86| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|1.97| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|2.22| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.644| |[[:human genes:p:prim1|PRIM1]]|0.518| |[[:human genes:p:polr2j3|POLR2J3]]|0.415| Global Fraction of Cell Lines Where Essential: 589/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|24/28| |blood|22/28| |bone|19/26| |breast|25/33| |central nervous system|39/56| |cervix|3/4| |colorectal|13/17| |esophagus|9/13| |fibroblast|1/1| |gastric|11/16| |kidney|19/21| |liver|20/20| |lung|64/75| |lymphocyte|14/16| |ovary|22/26| |pancreas|21/24| |peripheral nervous system|11/16| |plasma cell|8/15| |prostate|1/1| |skin|19/24| |soft tissue|7/9| |thyroid|1/2| |upper aerodigestive|18/22| |urinary tract|21/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 224 * **Expression level (log2 read counts)**: 6.55 {{:chemogenomics:nalm6 dist.png?nolink |}}